InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by McKenzie Kathryn B, Chief Financial Officer. Insider active across 1 company, notably Neogenomics INC. Cumulatively, 6 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €115k. History available since 21 December 2021. The latest transaction was filed on 11 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
2,100 shares@ US$9.070.0016% mcap22.7% of flowCommon StockSEC:0001077183-22-000002
2,100 shares@ US$9.070.0016% mcap11.3% of flowCommon StockSEC:0001077183-22-000002:0
30,572 shares0Common StockSEC:0001077183-21-000276:0
30,572 shares0Common StockSEC:0001077183-21-000276
1,846 shares@ US$35.000.0053% mcap77.3% of flowCommon StockSEC:0001077183-21-000260
1,846 shares@ US$35.000.0053% mcap38.7% of flowCommon StockSEC:0001077183-21-000260:0
6 of 6 declarations
About McKenzie Kathryn B
Kathryn B. McKenzie is the Chief Financial Officer and Chief Sustainability/Risk Officer at NEOGENOMICS INC. She is responsible for the company's financial management, including financial planning and performance analysis. McKenzie plays a key role in optimizing financial resources and NEOGENOMICS' growth strategy. Her expertise in finance and sustainability is essential for the company.
